Institute of Biomedical Sciences, Shandong Provincial Key Laboratory of Animal Resistance Biology, Collaborative Innovation Center of Cell Biology in Universities of Shandong, College of Life Sciences, Shandong Normal University, Jinan, 250014, People's Republic of China.
Drug Des Devel Ther. 2021 Sep 7;15:3773-3781. doi: 10.2147/DDDT.S322393. eCollection 2021.
Bacterial infections are predominantly treated with antibiotics, and resistance to antibiotics is becoming an increasing threat to our health. Pore-forming toxins (PFTs) are virulence factors secreted by many pathogenic bacterial strains, both in acute and chronic infections. They are special membrane-targeting proteins that exert toxic effects by forming pores in the cell membrane. Recent studies have elucidated the structure of PFTs and the detailed molecular mechanisms of their pathogenicity. Here, we discuss recent findings that highlight the regulatory mechanisms and important roles of two types of PFTs, α-PFTs and β-PFTs, in mediating the virulence of bacteria, and the therapeutic potential of targeting PFTs for antibacterial treatment. Therapeutic strategies based on PFTs are highly specific and may alleviate the issue of increasing resistance to antibiotics.
细菌感染主要用抗生素治疗,而抗生素耐药性正日益成为对我们健康的威胁。孔形成毒素(PFTs)是许多致病性细菌菌株在急性和慢性感染中分泌的毒力因子。它们是特殊的膜靶向蛋白,通过在细胞膜中形成孔来发挥毒性作用。最近的研究阐明了 PFTs 的结构和它们致病的详细分子机制。在这里,我们讨论了最近的发现,这些发现强调了两种类型的 PFTs(α-PFTs 和 β-PFTs)在介导细菌毒力方面的调节机制和重要作用,以及针对 PFTs 进行抗菌治疗的治疗潜力。基于 PFTs 的治疗策略具有高度特异性,可能缓解抗生素耐药性日益增加的问题。